Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment

K Laubach, T Turan, R Mathew… - Cancer Drug …, 2023 - pmc.ncbi.nlm.nih.gov
The development of immune checkpoint blockade (ICB) therapies has been instrumental in
advancing the field of immunotherapy. Despite the prominence of these treatments, many …

Targeting NAD metabolism for the therapy of age-related neurodegenerative diseases

F Li, C Wu, G Wang - Neuroscience bulletin, 2024 - Springer
As the aging population continues to grow rapidly, age-related diseases are becoming an
increasing burden on the healthcare system and a major concern for the well-being of …

[HTML][HTML] Nicotinamide riboside attenuates myocardial ischemia-reperfusion injury via regulating SIRT3/SOD2 signaling pathway

K Zhao, J Tang, H **e, L Liu, Q Qin, B Sun, Z Qin… - Biomedicine & …, 2024 - Elsevier
Ischemic heart disease invariably leads to devastating damage to human health.
Nicotinamide ribose (NR), as one of the precursors of NAD+ synthesis, has been discovered …

Discovery of a first-in-class CD38 inhibitor for the treatment of mitochondrial myopathy

Y Li, Y Liu, Y Zhang, Y Wu, Z **ng… - Journal of medicinal …, 2023 - ACS Publications
CD38 is a crucial NADase in mammalian tissues that degrades NAD+ and thus regulates
cellular NAD+ levels. Abnormal CD38 expression is linked to mitochondrial dysfunction …

NAD metabolism and heart failure: Mechanisms and therapeutic potentials

MA Walker, R Tian - Journal of Molecular and Cellular Cardiology, 2024 - Elsevier
Nicotinamide adenine dinucleotide provides the critical redox pair, NAD+ and NADH, for
cellular energy metabolism. In addition, NAD+ is the precursor for de novo NADP+ synthesis …

Immunometabolism: signaling pathways, homeostasis, and therapeutic targets

R Xu, X He, J Xu, G Yu, Y Wu - MedComm, 2024 - Wiley Online Library
Immunometabolism plays a central role in sustaining immune system functionality and
preserving physiological homeostasis within the organism. During the differentiation and …

Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling

G Kao, XN Zhang, F Nasertorabi, BB Katz, Z Li, Z Dai… - JACS Au, 2024 - ACS Publications
Nicotinamide adenine dinucleotide (NAD+) is required for a myriad of metabolic, signaling,
and post-translational events in cells. Its levels in tissues and organs are closely associated …

NAD+ enhancers as therapeutic agents in the cardiorenal axis

M Marín-Blázquez, J Rovira, MJ Ramírez-Bajo… - Cell Communication and …, 2024 - Springer
Cardiorenal diseases represent a complex interplay between heart failure and renal
dysfunction, being clinically classified as cardiorenal syndromes (CRS). Recently, the …

The Role of NAD+ Metabolism in Cardiovascular Diseases: Mechanisms and Prospects

H Li, Q Hu, D Zhu, D Wu - American Journal of Cardiovascular Drugs, 2024 - Springer
Nicotinamide adenine dinucleotide (NAD+) is a promising anti-aging molecule that plays a
role in cellular energy metabolism and maintains redox homeostasis. Additionally, NAD+ is …

The role of CD38 in ischemia reperfusion injury in cardiopulmonary bypass and thoracic transplantation: a narrative review

DA Gouchoe, A Vijayakumar, AH Aly… - Journal of Thoracic …, 2023 - pmc.ncbi.nlm.nih.gov
Background and Objective Ischemia reperfusion injury (IRI) is often the underlying cause of
endothelium breakdown and damage in cardiac or transplantation operations, which can …